BackgroundCheck.run
Search For

Richard Lai Mae J Ting, 5338 Woodranch Cir, Danville, CA 94506

Known as:
Richard Lai Mae Ting Richard E Ting Richard T Ing
Related to:
Aldo Ivan King 46 Yanine King

Richard Ting Phones & Addresses

38 Woodranch Cir, Danville, CA 94506    925-7361388   

2145 Watercress Pl, San Ramon, CA 94582    925-9689956   

7331 Carter Ave, Newark, CA 94560    510-7901667   

Peoria, IL   

Hayward, CA   

Belmont, CA   

Fremont, CA   

Get Report
Control this profile

Mentions for Richard Lai Mae J Ting

Career records & work history

Lawyers & Attorneys

Richard Ting Photo 1

Richard Ting - Lawyer

Office:
Vorys, Sater, Seymour and Pease LLP
Specialties:
Intellectual Property, Entertainment, and Technology Protection, Branding and Trademarks, Patents, Inventions, and Technology Protection, Patent Application
ISLN:
918627979
Admitted:
2005
University:
Brown University, Sc.B., 2000; Massachusetts Institute of Technology, S.M., 2001
Law School:
Harvard Law School, J.D., 2005
Richard Ting Photo 2

Richard Ting - Lawyer

Specialties:
Corporate Law, Securities, Business Law
ISLN:
912764168
Admitted:
1997
University:
University of California at Irvine, B.A., 1994
Law School:
Loyola Law School of Los Angeles, J.D., 1997

Medicine Doctors

Richard H. Ting

Specialties:
Oral & Maxillofacial Surgery
Work:
Santa Monica Oral Maxillofacial Surgery
2020 Santa Monica Blvd STE 530, Santa Monica, CA 90404
310-3151034 (phone) 310-3150077 (fax)
Education:
Medical School
University of California, Los Angeles David Geffen School of Medicine
Graduated: 2007
Conditions:
Tempromandibular Joint Disorders (TMJ)
Languages:
English, Korean, Spanish
Description:
Dr. Ting graduated from the University of California, Los Angeles David Geffen School of Medicine in 2007. He works in Santa Monica, CA and specializes in Oral & Maxillofacial Surgery. Dr. Ting is affiliated with Providence Saint Johns Health Center.

Richard Ting resumes & CV records

Resumes

Richard Ting Photo 45

Richard Ting

Location:
38 Woodranch Cir, Danville, CA 94506
Industry:
Pharmaceuticals
Work:
Impax Laboratories Oct 1995 - Jan 2016
Senior Vice President R and D, Global Pharmaceuticals Division
Education:
University of California, Berkeley 1990 - 1995
Bachelors, Bachelor of Science, Chemistry University of California
Skills:
R&D, Biopharmaceuticals, Sop, Biotechnology, Pharmaceutical Industry, Clinical Development, Fda, Technology Transfer, Cross Functional Team Leadership, Validation, Capa, Gmp, Change Control, Regulatory Affairs, Life Sciences
Richard Ting Photo 46

Managing Director

Work:

Managing Director
Richard Ting Photo 47

Richard Ting

Publications & IP owners

Us Patents

Combination Immediate Release Sustained Release Levodopa/Carbidopa Dosage Forms

US Patent:
2003022, Dec 4, 2003
Filed:
May 29, 2002
Appl. No.:
10/158412
Inventors:
Larry Hsu - Santa Clara CA, US
Richard Ting - Newark CA, US
Charles Hsiao - Pleasanton CA, US
International Classification:
A61K031/198
A61K009/22
US Classification:
424/468000, 514/567000
Abstract:
Dosage forms containing both immediate release and sustained release components for the treatment of ailments associated with depleted amounts of dopamine in brain tissue of a patient. The dosage forms contain a combination of carbidopa and levodopa.

Controlled Release Muscarinic Receptor Antagonist Formulation

US Patent:
2009021, Aug 27, 2009
Filed:
Feb 26, 2008
Appl. No.:
12/037124
Inventors:
Felix S. Lai - Hayward CA, US
Richard Ting - San Ramon CA, US
Lee Foong Siew - San Ramon CA, US
King Yu-Kuang Chuang - Los Altos CA, US
Sibel Ucpinar - Cupertino CA, US
International Classification:
A61K 9/14
A61K 31/137
A61P 21/00
US Classification:
424497, 424490, 514648
Abstract:
An oral controlled release pharmaceutical composition for muscarinic receptor antagonist, preferably tolterodine, that employs a drug core, a rapidly disintegrating or rapidly dissolving coating applied to the drug core and a controlled release coating.

Enteric Coated Hydrophobic Matrix Formulation

US Patent:
2010000, Jan 7, 2010
Filed:
Jul 3, 2008
Appl. No.:
12/167876
Inventors:
FELIX S. LAI - Hayward CA, US
Richard Ting - San Ramon CA, US
Christopher A. Simpson - San Jose CA, US
Bernard Lee - Hayward CA, US
Sibel Ucpinar - Mountain View CA, US
International Classification:
A61K 9/28
A61K 31/135
A61K 31/19
A61K 31/195
A61K 31/40
A61K 31/485
A61K 31/34
US Classification:
424474, 514646, 514557, 514561, 514423, 514282, 514468
Abstract:
An enteric coated hydrophobic matrix tablet for soluble, freely soluble and very soluble drugs.

Multiparticulate Selective Serotonin And Norepinephrine Reuptake Inhibitor Formulation

US Patent:
2010004, Feb 18, 2010
Filed:
Aug 15, 2008
Appl. No.:
12/192609
Inventors:
Felix Lai - Hayward CA, US
Richard Ting - San Ramon CA, US
Christopher A. Simpson - San Jose CA, US
Victoria Kellogg - Fremont CA, US
Sibel Ucpinar - Mountain View CA, US
International Classification:
A61K 9/54
A61K 9/14
A61K 31/381
A61K 9/22
A61K 9/36
A61K 9/32
US Classification:
424458, 424490, 424494, 424497, 424468
Abstract:
A multiparticulate oral pharmaceutical composition that contains a plurality of delayed release coated selective serotonin and norepinephrine reuptake inhibitor particles.

Pharmaceutical Dosage Forms And Methods Of Manufacturing Same

US Patent:
2010016, Jul 1, 2010
Filed:
Dec 30, 2009
Appl. No.:
12/649943
Inventors:
Dong Yan - Palo Alto CA, US
Lee Foong Siew - Dublin CA, US
Richard Ting - Danville CA, US
Tzu-Yuan Chen - San Jose CA, US
Mahendra Sudhakar Pawar - Santa Rosa CA, US
International Classification:
A61K 9/26
A61K 9/50
A61K 31/216
A61P 9/10
A61P 3/06
B05D 1/02
US Classification:
424465, 424494, 424497, 514543, 427 215
Abstract:
The invention provides solid dispersions of at least one insoluble active pharmaceutical ingredient, pharmaceutical dosage forms comprising the solid dispersions, and methods of manufacturing same. In an embodiment, a solid dispersion of the present invention includes a plurality of coated particles comprising inert particles with a coating, wherein the coating comprises an insoluble active pharmaceutical ingredient dispersed in a hydrophilic polymer, and wherein the inert particles comprise nonpareils; and a plurality of granules comprising an insoluble active pharmaceutical ingredient with at least one pharmaceutically acceptable excipient. In an embodiment, the insoluble active pharmaceutical ingredient in the coating and the insoluble active pharmaceutical ingredient of the granules are the same type. A solid dispersion of the present invention may optionally be encapsulated in capsules or compressed into a tablet. Also disclosed are methods of making solid dispersions and methods of reducing plasma triglyceride and increasing high-density lipoprotein employing the solid dispersion.

Possible Relatives

Daniel K Ting  Daphne T Ting  Eric Ting  Eryi Y Ting  Eva L Ting  Frank K Ting  Grace Y Ting  Richard O Johnson  Richard E Stamps  Richard E Stanbrough 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.